Although it has been suggested that pulmonary sequestration of leukocytes could account for membrane-dependent white blood cell depletion in HD, direct evidence in patients is still lacking. Therefore a study was initiated to test whether and how leukocytes distribute in the lung circulation during HD with different membranes. Thirteen patients suffering from chronic renal failure underwent lung scintigraphy during HD with cuprophane (n = 3), hemophane (n = 8) and polysulfone (n = 2) lowflux capillary dialyzers. Isolated autologous leukocytes were labelled with 99m-Technetium and reinfused before starting HD. Distribution of leukocyte related activity was registered by lung scintigraphy. In comparison to normal lung scintigraphy performed without HD, an impressive redistribution peak was demonstrated 10-20 min after the start of HD with cuprophane and also to a lesser extent with hemophane. When HD was performed with polysulfone the decrease in activity was delayed but no real redistribution was obtained.
In accordance with other phenomena, such as peripheral leukopenia and changes in granulocyte oxidative metabolism, pulmonary sequestration of leukocytes takes place in man in the initial phase of HD and appears to be strongly dependent on the type of membrane. (Int J Artif Organs 1990; 13: 729-36)
CraddockPR, FehrJ, BrighamKL, Complement and leukocyte mediated pulmonary dysfunction in hemodialysis. N Engl J Med1977; 296: 769–74.
9.
CraddockPR, HammerschmidtDE, MoldowCF, YamadaO, JacobHS. Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage. Semin Hematol1979; 16: 140–7.
10.
CraddockPR, HammerschmidtDE. Complement-mediated granulocyte activation and down-regulation during hemodialysis. ASAIO1984; 7: 50–6.
11.
JosephK, DamannV, EngeroffG, Markierung von Leukozyten mit 99m-Technetium-HM-PAO: Erste klinische Ergebnisse. Nuc-Compact1986; 5: 277–83.
12.
JosephK, HöffkenH, BossletK, SchorlemmerHU. In vivo labelling of granulocytes with 99m-Tc anti-NCA monoclonal antibodies for imaging inflammation. Eur J Nucl Med1988; 14: 367–73.
13.
SchorlemmerHU, BossletK, DickneiteG, LübenG, SedlacekHH. Studies on the mechanisms of action of the immunomodulator bestatin in various screening test systems. Behring Inst Mitt1984; 74: 157–73.
14.
AthensJW, RaabSO, HaabOP, Leukokinetic studies. III. The distribution of granulocytes in the blood of normal subjects. J Clin Invest1961; 40: 159–64.
15.
AthensJW, RaabSO, HaabOP, Leukokinetic studies. IV. The total blood, circulation and marginating granulocyte turnover rate in normal subjects. J Clin Invest1961; 40: 989–95.
16.
BiermannSA, KellyKH, CordesFL, ByronRL, PolhemusJA, RapportS.The release of leukocytes and platelets from pulmonary circulation by epinephrine. Blood1952; 7: 683–92.
17.
JoyceRA, BoggsDR, HasibaU, StrodesCH. Marginal neutrophil pool size in normal subjects and neutropenic patients as measured by epinephrine infusionJ Lab Clin Med1984; 88: 614–20.
18.
AthertonA, BornGVR. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leukocytes to blood vessel walls. J Physiol Lond1973; 222: 447–73.
19.
LienDC, WagnerWWJr, CapenRL, Physiological neutrophil sequestration in the lung: visual evidence for localization in capillaries. J Appl Physiol1987; 62: 1236–43.
20.
HaslettC, HensonPM. Endotoxin effects in neutrophil circulation and sequestration in the lung (Abstract). Am Rev Respir Dis1984; 129: A18.
21.
MuirAL, CruzM, MartinBA, ThommasenH, BelzbergA, HoggJC. Leukocyte kinetics in the human lung: role of exercise and catecholamines. J Appl Physiol1984; 57: 711–9.
22.
BischelMD, ScolesBG, MohlerJG. Evidence for pulmonary microembolization during hemodialysis. Chest1975; 67: 335.
23.
FawcettS, HoenichNA, WoffindinC, WardMK. Influence of high permeability synthetic membranes on gas exchange and lung function during hemodialysis. Contr Nephrol1985; 46: 83–91.
24.
JahnH, BaulerM, SchohnD.Hemodynamic studies in chronic dialysis patients with a polysulfone hemodiafilter. Contr Nephrol1985; 46: 151–61.
25.
DanielsonA, FreyschussU, BergstromJ.Effects of blood-dialyzer interaction (sham-dialysis) on hemodynamics and oxygen tension in healthy men. Proc EDTA-ERA1984; 21: 156–61.
26.
VanholderRC, PauwelsRA, Vanden BogaerdeDF, LamontHH, van der StraetenME, RingoirSM. Cuprophan reuse and intradialysic changes of lung diffusion capacity and blood gases. Kidney Int1987; 32: 117–22.
27.
De BackerWA, VerpootenGA, BorgonjonDJ, VermeireRA, LinsRR, DebroME. Hypoxyemia during hemodialysis: effects of different membranes and dialysate compositions. Kidney Int1983; 23: 738–43.
28.
KleebergUR, FranzHG, WalbD, FinkeJ.Über die durch Hämodialyse induzierte passagere Granulozytopenie. In: von DittrichP, SkrabalF, eds. Aktuelle Problerne der Dialyseverfahren und der Niereninsuffizienz, Friedberg/Hessen: Verlag Carl Bindernagel, 1971; 88–93.
29.
MacGregorRR. Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrine and glucocorticoids. Ann Intern Med1977; 86: 35–9.
30.
GuerroIC, SchreiberAD, MacGregorRR. Studies of the plasma factor which augmented granulocyte adherence during hemodialysis. Nephron1981; 27: 79–83.
FlemmingK, NielsenAH, PedersenJO, On the kinetics of complement activation, leukopenia and granulocyte-elastase release induced by hemodialysis. Scand J Clin Lab Invest1985; 45: 759–66.
33.
HakimRM. Clinical sequelae of complement activation in hemodialysis. Clinical Nephrol1986; 26 (S1); 9–12.
34.
NguyenAT, LathiasC.Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and within in vitro microamounts of whole blood. Kidney Int1985; 28: 158–67.
35.
TettaC, CamussiG, SegoliniG, Direct interaction between polymorphonuclear neutrophils (PMN) and dialysis membranes: role of the electrical charges, Kidney Int1986; 29: 609.
36.
TettaC, SegoliniG, CamussiG, In vitro complement-independent activation of human neutrophils by hemodialysis membranes: role of the net electric charge. Int J Artif Organs1987; 10: 83–8.
37.
KuwaharaT, MarkertM, WautersJP. Neutrophil oxygen radical production by dialysis membranes. Nephrol Dial Transplant1988; 3: 661–5.
38.
AljamaP, BirdPAE, WardMK, Hemodialysis induced leukopenia and activation of complement: effects of different membranes. Proc Eur Dial Transplant Ass1978; 15: 144–53.
HörlWH, RiegelW, SchollmeyerP.Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes. Nephron1987; 45: 272–6.
41.
KolbG, FischerW, MüllerT, Granulocyte-related bioincompatibility of hemodialysis: inhibition of oxidative metabolism, degranulation reaction, enzyme release and leukocyte sequestration in the lung. Int J Artif Organs1989; 12: 294–8.
42.
HörlWH, JochumM, NeumannS, Freisetzung von Granulozyten-Elastase bei akutem Nierenvetsagen während der Hämodialysebehandlung bei chronisch niereninsuffizienten Patienten. In: JochumM, GablF, GreilingH, FritzH, eds. Neue Wege der Entzündungsdiagnostik — PMN Elastase.Darmstadt1985; 43–51.
43.
SchaeferRM, HeidlandA, HörlWH. Release of leukocyte elastase during hemodialysis. Effects of different dialysis membranes. Contr Nephrol1985; 46: 109–17.
44.
GraltT, SchorothP, De PalmaJR, GordonA.Leukocyte dynamics with three types of hemodialyzers. Trans Am Soc Artif Internal Organs1969; 15:45–9.
45.
KolbG.Die Biokompatibilität der Hämodialysebehandlung. Aktuelle Nephrol1987; 20: 697–708.
MarkertM, HeierliC, KuwaharaT, FreiJ, WautersJP. Dialyzed polymorphonuclear neutrophil oxidative metabolism during dialysis: a comparative study with 5 new and reused membranes. Clinical Nephrol1988; 29: 129–36.
48.
JanoffA.Proteases and lung injury. A state of the art mini-review. Chest1983; 54: 835–9.
49.
CurnutteJT, BabiorGM. Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes. J Clin Invest1974; 53: 1662–72.
50.
StosselTP. Phagocytosis. N Engl J Med1974; 290: 717–23, 774-80, 833-9.
51.
RootRK, MetcalfJ, OshinoN, ChangeB.H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and regulating factors. J Clin Invest1975; 55: 945–55.
52.
BeattyK, BiethJ, TravisJ.Kinetics of association of serine proteinases with native and oxidized alpha-I-proteinase inhibitor and alpha-I-antichymotrypsin. J Biol Chem1980; 255: 3931–4.
53.
CongerJD, HammondWS, AlfreyAC, ContigugliaSR, StanfordRE, HufferWE. Pulmonary calcification in chronic dialysis patients: clinical and pathologic studies. Ann Intern Med1975; 83: 330–6.
